STAR and neoplasm: Thirdly, the small clinical sample size and focus on SOC limit our ability to assess the correlation between STAR + cells and clinical features, and further exploration of STAR + cells in other tumor types is needed, with ongoing sample collection and collaboration to validate these findings.